Therapies from Fucoidan: New Developments
Since our last review in 2015, the study and use of fucoidan has extended in several research areas. Clinical use of fucoidan for the treatment of renal disease has become available and human safety studies have been undertaken on radiolabeled fucoidan for the purpose of imaging thrombi. Fucoidan ha...
Main Authors: | J. Helen Fitton, Damien N. Stringer, Ah Young Park, Samuel S. Karpiniec |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/17/10/571 |
Similar Items
-
Fucoidan and Lung Function: Value in Viral Infection
by: J. Helen Fitton, et al.
Published: (2021-12-01) -
Fucoidan But Not 2′-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae
by: Malcolm Turk Hsern Tan, et al.
Published: (2021-03-01) -
Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model
by: Claire Richards, et al.
Published: (2020-05-01) -
Therapies from Fucoidan; Multifunctional Marine Polymers
by: Janet Helen Fitton
Published: (2011-09-01) -
Topical Benefits of Two Fucoidan-Rich Extracts from Marine Macroalgae
by: J. Helen Fitton, et al.
Published: (2015-04-01)